IDEXX Laboratories マネジメント
マネジメント 基準チェック /44
IDEXX Laboratoriesの CEO はJay Mazelskyで、 Jun2019年に任命され、 の在任期間は 5.42年です。 の年間総報酬は$ 11.52Mで、 8.7%給与と91.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.1%を直接所有しており、その価値は$ 34.21M 。経営陣と取締役会の平均在任期間はそれぞれ5.4年と7.7年です。
主要情報
Jay Mazelsky
最高経営責任者
US$11.5m
報酬総額
| CEO給与比率 | 8.7% |
| CEO在任期間 | 5.4yrs |
| CEOの所有権 | 0.1% |
| 経営陣の平均在職期間 | 5.4yrs |
| 取締役会の平均在任期間 | 7.7yrs |
経営陣の近況
Recent updates
At US$420, Is It Time To Put IDEXX Laboratories, Inc. (NASDAQ:IDXX) On Your Watch List?
Nov 19
IDEXX Laboratories Q3: Weak End-Market Demand Continues
Nov 11Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects
Oct 28Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
Oct 15We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease
Sep 18A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Sep 05What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?
Aug 20IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits
Aug 12A Look Into IDEXX Laboratories' (NASDAQ:IDXX) Impressive Returns On Capital
Jul 02Looking For Fast Growth In Healthcare? IDEXX Has You Covered
Jun 28Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
Jun 04Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?
May 21IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 03What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You
Apr 27IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet
Apr 11IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)
Apr 08Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jan 30IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified
Jan 16Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
Jan 15IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit
Dec 31IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly
Dec 15Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching
Oct 26Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
Oct 10Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Sep 07Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jul 04These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well
May 31At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?
Apr 05Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly
Feb 22Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching
Jan 05Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Nov 24When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Sep 20IDEXX Laboratories: Outstanding Business, But Valuation Is Key
Aug 15These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well
Aug 15IDEXX Laboratories Stock Is Very Expensive
Aug 08IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M
Aug 02Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?
Jul 26Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today
Jul 12Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jun 16IDEXX Laboratories: Great Business, But Still Overvalued
May 25CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$866m |
| Jun 30 2024 | n/a | n/a | US$846m |
| Mar 31 2024 | n/a | n/a | US$867m |
| Dec 31 2023 | US$12m | US$1m | US$845m |
| Sep 30 2023 | n/a | n/a | US$823m |
| Jun 30 2023 | n/a | n/a | US$791m |
| Mar 31 2023 | n/a | n/a | US$699m |
| Dec 31 2022 | US$10m | US$1m | US$679m |
| Sep 30 2022 | n/a | n/a | US$670m |
| Jun 30 2022 | n/a | n/a | US$664m |
| Mar 31 2022 | n/a | n/a | US$735m |
| Dec 31 2021 | US$9m | US$977k | US$745m |
| Sep 30 2021 | n/a | n/a | US$757m |
| Jun 30 2021 | n/a | n/a | US$728m |
| Mar 31 2021 | n/a | n/a | US$674m |
| Dec 31 2020 | US$7m | US$814k | US$582m |
| Sep 30 2020 | n/a | n/a | US$497m |
| Jun 30 2020 | n/a | n/a | US$460m |
| Mar 31 2020 | n/a | n/a | US$437m |
| Dec 31 2019 | US$7m | US$632k | US$428m |
| Sep 30 2019 | n/a | n/a | US$423m |
| Jun 30 2019 | n/a | n/a | US$407m |
| Mar 31 2019 | n/a | n/a | US$390m |
| Dec 31 2018 | US$3m | US$555k | US$377m |
| Sep 30 2018 | n/a | n/a | US$330m |
| Jun 30 2018 | n/a | n/a | US$307m |
| Mar 31 2018 | n/a | n/a | US$284m |
| Dec 31 2017 | US$2m | US$469k | US$263m |
報酬と市場: Jayの 総報酬 ($USD 11.52M ) は、 US市場 ($USD 12.73M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Jayの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Jay Mazelsky (63 yo)
5.4yrs
在職期間
US$11,519,309
報酬
Mr. Jonathan J. Mazelsky, also known as Jay, serves as Independent Director at DENTSPLY SIRONA Inc. since May 24, 2023. He has been President, Chief Executive Officer and Director at IDEXX Laboratories, In...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 5.4yrs | US$11.52m | 0.10% $ 34.2m | |
| CFO, Executive VP & Treasurer | 10.8yrs | US$3.85m | 0.060% $ 20.5m | |
| Executive VP and GM of Reference Laboratories & Information Technology | 4.8yrs | US$2.92m | 0.0086% $ 2.9m | |
| Senior Vice President of Global Operations | 7.2yrs | データなし | データなし | |
| Senior Vice President of Commercial Finance & Sales Operations | 9.8yrs | データなし | データなし | |
| Executive VP & CTO | 3.3yrs | データなし | データなし | |
| Senior VP & Chief Information Officer | 8.8yrs | データなし | データなし | |
| Executive VP | no data | US$1.88m | 0.0068% $ 2.3m | |
| Executive VP & Chief Human Resources Officer | 2.7yrs | データなし | 0.00022% $ 75.4k | |
| Senior VP & Chief Revenue Officer | no data | データなし | 0.0084% $ 2.9m | |
| Executive VP and GM of Point of Care Diagnostics & Telemedicine | no data | データなし | 0.013% $ 4.5m | |
| Senior Vice President of Research & Development | 4.8yrs | データなし | データなし |
5.4yrs
平均在職期間
55yo
平均年齢
経験豊富な経営陣: IDXXの経営陣は経験豊富で経験豊富です（平均在職期間は5.4年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 5.1yrs | US$11.52m | 0.10% $ 34.2m | |
| Independent Director | 12.3yrs | US$367.66k | 0.0074% $ 2.5m | |
| Independent Director | 10.7yrs | US$362.66k | 0.0031% $ 1.1m | |
| Independent Director | 9.3yrs | US$367.66k | 0.0021% $ 719.8k | |
| Independent Director | 7.3yrs | US$350.16k | 0.0024% $ 826.1k | |
| Independent Non-Executive Chairman | 8.1yrs | US$495.02k | 0.0096% $ 3.3m | |
| Independent Director | 11.3yrs | US$335.16k | 0.011% $ 3.8m | |
| Independent Director | 1.3yrs | US$258.89k | 0.00025% $ 85.7k | |
| Independent Director | 5.3yrs | US$342.66k | 0% $ 0 | |
| Independent Director | 4yrs | US$335.16k | 0.00095% $ 325.6k |
7.7yrs
平均在職期間
62yo
平均年齢
経験豊富なボード: IDXXの 取締役会 は 経験豊富 であると考えられます ( 7.7年の平均在任期間)。